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Abstract 
The objective of this study was to determine the effects of topical 0.5% tropicamide, 1% atropine sulphate and 10% 
phenylephrine hydrochloride ophthalmic solutions on intraocular pressure (IOP) and horizontal pupil diameter (HPD) 
in the dog during the first hour after treatment. Forty clinically and ophthalmologically normal canine patients 
(between the ages of 2 and 6 years) of varying breed and sex were used in this study. Animals were randomly divided 
into four groups of ten and given one drop of tropicamide, atropine, phenylephrine or saline into one eye. IOP and 
HPD were measured in both eyes every 5 minutes for 60 minutes. Tropicamide increased IOP by 8.8±4.0 mmHg 35 
minutes post-treatment compared to pre-treatment (P<0.01) only in treated eye. IOP in the contralateral eye did not 
increase. With atropine the maximum increase in IOP was 2.6±2.8 mmHg at 20 minutes post treatment in the treated 
eye (P<0.01). IOP in the contralateral eye did not increase. Phenylephrine increased IOP by 2.3±2.1 mmHg (P<0.05) 
10 minutes after treatment. Also in the untreated eye IOP increased by 2.3±2.1 mmHg, 20 minutes post-treatment. 
Maximum HPD in eyes treated with tropicamide occurred at 55 minutes and with atropine at 60 minutes. There were 
no HPD changes in the contralateral, untreated eye. Topical 10% phenylephrine showed maximal pupil dilation 60 
minutes after treatment, but the HPD of the – untreated eye slightly decreased at 15 minutes, but this change only 
reached statistical significance at 40 min post- treatment (P<0.05). Normal saline showed no influence on IOP or HPD.  
The drugs investigated here show a significant increase in IOP after mydriatics. 
Keywords: Atropine sulphate, Horizontal pupil diameter, Intraocular pressure, Phenylephrine, Tropicamide. 
_____________________________________________________________________________________________ 
 
Introduction 
In ophthalmology mydriatics – specifically tropicamide 
hydrochloride and atropine sulphate – are employed to 
provide pupil dilation: during examination of the 
posterior segment of the eye (tropicamide) and as 
therapeutic agents for treatment of uveitis (atropine) by 
relieving ciliary spasm through cycloplegia and 
preventing formation of synechiae through mydriasis. 
The phenylephrine is used to localize the site of 
sympathetic denervation in Horner’s syndrome, 
producing mydriasis as part of sympathomimetic action 
(Smith and Raynard 1992; Ward, 1998).  
In humans an increase of intraocular pressure (IOP) has 
been observed after use of topical mydriatics such as 
atropine (Gartner and Billet, 1957), tropicamide and 
phenylephrine (Harris 1968; Harris and Galin, 1969; 
Rengstorff and Doughty, 1982) both in normal subjects 
and in patients with narrow filtration angle glaucoma 
(Harris and Galin, 1969) and with primary open angle 
glaucoma (Shaw and Lewis, 1986; Marchini et al., 
2003). Latest report in five years old girl presented to 
the hospital for a routine retina check-u, after pupil 
dilation with 1 % tropicamide and 10 % phenylephrine 
for retinal examination, showed an acute elevation of 
intraocular pressure (Wu et al., 2015).  
Effects of topical 1% atropine, 0.5% tropicamide, 1% 
homatropine, 10% phenylephrine, and 2% ibopamine 
on IOP and pupil diameter has been investigated in 
sheep. Topical atropine, tropicamide, and homatropine 
induced pupil dilation but did not change IOP in eyes 
of healthy sheep, but phenylephrine did not change any 
of the parameters evaluated (Ribeiro et al., 2014). 
Hacker and Farver (1988) investigated whether use of 
mydriatics could cause an increase in intraocular 
pressure in dogs and reported negative findings. 
However, these researchers measured the IOP before 
drug administration and at maximal pupil dilation but 
never during the process of pupil dilation, but 
Grozdanic et al. (2010) showed increase of IOP in dogs 
with closed angle glaucoma.  
The parasympatholytic agent tropicamide is a 
cholinergic antagonist used in animals for pupil dilation 
because of its rapid action and short duration (Marchini 
et al., 2003). In several studies with dogs neither 
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unilateral nor bilateral application of 1% tropicamide 
was shown to cause significant changes of IOP 
measured after maximal pupil dilation (Hacker and 
Farver 1988; Molleda et al., 1988; Wallin-Hakanson 
and Wallin-Hakanson, 2001), although one group of 
researchers noticed that Siberian Huskies had a greater 
IOP variability after dilation (Taylor et al., 2007). A 
study focused on the effects of 0.5% topical 
tropicamide in Spanish Water Hounds reported no 
significant changes in IOP after unilateral application 
(Molleda et al., 1988) but again, changes in IOP were 
not measured during dilation. 
A previous study in cats showed IOP increases in both 
eyes 30 min after unilateral treatment of 0.5% 
tropicamide in the right eye. However, 60 min after 
treatment the IOP increase of the right eye was 
significantly greater than the left (Stadtbaumer et al., 
2002). In a more recent study by the same author the 
effects of topical 1% atropine and 10% phenylephrine 
in cats demonstrated a significant IOP increase after 
atropine, but no effect after phenylephrine. The highest 
IOP was measured in the treated eye between 5 and 28 
h after treatment and these differences were statistically 
significant at 1, 3, 6, 12 and 16 h post-treatment 
(Stadtbaumer et al., 2006). In study with normal cats 
and cats with inherited primary glaucoma, topical 0.5% 
tropicamide increased IOP in normal cats those with 
primary inherited glaucoma (Gomes et al., 2011).  
Contradictory findings regarding the effects of atropine 
on the dynamics of aqueous humour outflow have been 
reported (Green and Elijah, 1981; Miichi and Nagataki, 
1982). Some authors suggested that atropine could 
change aqueous outflow through cycloplegic actions 
(Harris, 1968; Valle, 1974); others suggested that 
mechanical obstruction of iridocorneal angle might be 
the possible cause of IOP increase (Stadtbaumer et al., 
2006). However, these researchers observed that the 
maximum dilation of the pupil lasted longer than the 
statistically significant increase of the IOP in cats, 
arguing against mechanical obstruction of iridocorneal 
angle (Stadtbaumer et al., 2006).  
Few data exist in literature concerning the effects of 
phenylephrine on the IOP in animals. In monkeys there 
were no significant changes in the IOP two hours after 
a single unilateral application of 5% phenylephrine, but 
in the same study in human patients IOP was found to 
have increased significantly (Takayama et al., 2004). In 
another study with human subjects, 10% phenylephrine 
did not cause significant increase in IOP after treatment 
(Marchini et al., 2003). 
Regarding the effects of tropicamide on horizontal 
pupil diameter (HPD) in dogs, the small amount of data 
in the literature shows significant HPD increase after 
topical 0.5% tropicamide application in both eyes 
(Wallin-Hakanson and Wallin-Hakanson, 2001). 
Maximal pupil dilation in cats was observed 2h after 
topical 0.5% tropicamide (Stadtbaumer et al., 2002). 
Tropicamide causes significant mydriasis in dogs with 
and without Therapeutic soft contact lenses (Hatzav et 
al., 2016). With regard to atropine, maximal pupil 
dilation was obtained 30-60 min after topical 
application in dogs, cats and cattle (Gelatt et al., 1973, 
1995; Gelatt and MacKey, 1998). In one feline study, 
HPD started to decrease 24 hours after the topical 
atropine was administered and after 96 hours the pupil 
returned to pre-treatment size (Stadtbaumer et al., 
2006).  
There are contradictory findings in the literature about 
the effect of phenylephrine on HPD. In cats there is a 
poor mydriatic effect after application of 10% 
phenylephrine (Stadtbaumer et al., 2006). In Rhesus 
monkeys the maximal pupil dilation occurred 15 
minutes after application of two doses of 10% 
phenylephrine, although the pupils remained dilated 
more than 65 minutes (Marchini et al., 2003; Ostin and 
Glasser, 2004). Rubin and Wolfes (1962), tested 
phenylephrine in dogs and found maximal dilation at 
approximately 2 hours. 
In the most studies researchers have looked at the IOP 
at the time of maximal pupil dilation, therefore, our 
goal in this study was to determine the IOP in the eye 
immediately after administration of topical mydriatics 
and in five minutes intervals during the first hour after 
treatment. The purpose of this study was to determine 
the effects of topical mydriatics - 0.5% tropicamide, 1% 
atropine sulphate, and 10% phenylephrine on the IOP 
and the HPD in the canine eye during the first hour after 
treatment.  
Materials and Methods 
Data 
All animals examined were outpatients at Clinical 
Institute of the Faculty of Veterinary Medicine at the 
Latvia University of Agriculture and at the Queen’s 
Veterinary School Hospital, University of Cambridge. 
This study was approved by the Committee for Animal 
Protection and Ethical use of Latvian State Food and 
Veterinary Service and by the Ethics Committee of the 
Department of Veterinary Medicine, University of 
Cambridge. In all cases informed consent was obtained 
from the pet owners for the study. 
All animals included in this study were examined by 
the same person clinically and ophthalmologically, to 
ensure they were both systemically and 
ophthalmologically healthy. The clinical examination 
included signalment (animal breed, age and sex were 
recorded), general appearance, vital signs (body 
weight, temperature, heart/pulse rate, respiratory rate), 
physical examination (systems approach). The ocular 
examination included direct and indirect 
ophthalmoscopy (Keeler Practitioner, Windsor, UK), 
monocular ophthalmoscopy with the Pan Optic 
ophthalmoscope (Welch Alynn, Romford, UK) and slit 
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lamp biomicroscopy (Kowa SL15, Nagoya, Aichi, 
Japan). Tonometry with the Tonovet tonometer 
(TonoVet®, Tiolat Ltd. Finland) was a part of the initial 
examination. Four groups, each containing 10 healthy, 
randomly assigned dogs of different sexes and breeds 
were used.  
The first group all animals received one drop of 0.5% 
tropicamide (Alcon – Couvreur, Belgium) in the right 
eye, in the second group one drop of 1% atropine 
sulphate (Martindale Pharmaceuticals Ltd. UK) in the 
right eye. In the third group one drop of 10% 
phenylephrine hydrochloride was used in the right eye. 
In the fourth control group, one drop of normal saline 
was used in the right. The effects of mydriatics on the 
IOP and the HPD were determined in all groups. 
In all treatment groups the first IOP and HPD 
measurement was taken before treatment (T0). After 
treatment, IOP and HPD were recorded every five 
minutes in both eyes (T5; T10; …T60/65). During all 
measurements, the animals were handled gently to 
avoid any tension on the animal’s neck which might 
influence IOP neck (Pauli et al., 2006). 
All tonometric measurements were performed by the 
same person employing rebound tonometry with the 
Tonovet tonometer (TonoVet®, Tiolat Ltd. Finland), 
using values that were less than a 5% standard deviation 
among six measurements. Use of topical anaesthesia is 
not required for this tonometer. Horizontal pupil 
diameter was measured with Jameson calipers under 
fixed light conditions every five minutes as described 
above. All measurements were done at approximately 
same time of day (9.00-11.00 am) because of the effects 
of light conditions at different times of day on the IOP 
and the HPD (Gelatt et al., 1981; Giannetto et al., 
2009). 
Statistical method 
To determine the effect of topical tropicamide, atropine 
and phenylephrine, the arithmetic mean values (X) and 
standard deviation (SD) of the IOP and the HPD were 
calculated for each eye separately. Changes in the IOP 
and the HPD between eyes and over time period were 
evaluated using a paired two-sample repeated measures 
T-test. P values less than 0.05 were considered to be 
statistically significant. 
Results 
No signs of ocular irritation or pain were detected in 
animals during the study.  
Group 1 (tropicamide) 
Initial pre-treatment IOP are shown in Table 1. Mean 
IOP values before topical tropicamide application 
between right and left eye were not significantly 
different (P=0.27). The IOP increased from the first 
post-treatment measurement in the treated eye and at 
T35 time point IOP had increased from the pre-
treatment value of mean 8.8±4.0 mmHg in reaching a 
maximum 21.6±4.1 mmHg (P=0.002) (Fig. 1.). From 
this time forward IOP continually decreased until at 60 
minutes after treatment the IOP had returned to a T0 
values (P>0.05). 
 
 
Fig. 1. Effect of unilateral application of 0.5% tropicamide on 
the intraocular pressure (mean values) in dogs. 
 
The IOP in the contralateral eye did not significantly 
increase throughout the treatment period: the IOP 
values were between 12.5±1.4 mmHg and 13.5±1.1 
mmHg (Table 1). The increase in IOP in the treated eye 
compared to the untreated eye was statistically 
significant (P=0.002) from the T5 of the measurement 
period.  
Our results concerning the effects of tropicamide on the 
HPD are shown in Table 2. Before treatment there were 
no significant differences in the HPD between the eyes. 
HPD at T5 was increasing relatively to T0 and 
continued to increase, gaining a maximum mean value 
of 13.2±1.7 mm at T55. During the last five minutes the 
HPD decreased but still was significantly higher than 
pre-treatment values (P<0.05).  The increase in pupil 
diameter from the T0 value until the end of the study 
was 6.6±1.2mm (Fig. 2). 
 
 
Fig. 2. Effect of 0.5% tropicamide on the horizontal pupil 
diameter (mean values) in dogs. 
 
Differences in the HPD between the treated and 
untreated eye and control group were statistically 
significant (P<0.003).  
Group 2 (atropine sulphate) 
In the second group, there were no significant 
differences in IOP between the left and right eyes 
before application of 1% atropine sulphate (P>0.05) 
(Table 1).  
The dynamics of IOP after topical application of 1% 
atropine sulphate are shown in Figure 3.  
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Table 1. Effect of mydriatics on intraocular pressure (mean values ± SD) in the dog’s right and left eye. 
 
Topical 
mydriatics 
Right eye (treated eye) Left eye (untreated eye) 
Initial IOP 
(mean ± SD) 
Maximal IOP 
(mean ± SD), time 
% of IOP  
increase 
Initial IOP 
(mean ± SD) 
Maximal IOP 
(mean ± SD), time 
% of IOP  
increase 
Tropicamide 12.8 ± 1.4 
21.6 ± 4.1 
(35min) 
68.8% ** 13.1 ± 1.1 
13.5 ± 1.1 
(50 min) 
3.1% 
Atropine sulphate 17.7 ± 3.1 
20.3 ± 3.1 
(20 min) 
14.7 %** 17.3 ± 2.8 
18.1 ± 3.9 
(15 min) 
4.6 % 
Phelylephrine 
hydrochloride 
15.0 ± 3.3 
17.3 ± 4.1 
(10 min) 
15.3% 14.0 ± 2.8 
16.3 ± 2.3 
(20 min) 
16.4% 
Saline 16.6 ± 2.0 
17.3 ± 2.6 
(15 min) 
4.2 % 16.6 ± 2.0 
17.3 ± 2.6 
(15 min) 
4.2 % 
** P < 0.01 
 
 
 
Fig. 3. Effect of unilateral application of 1% atropine sulphate 
on the intraocular pressure (mean values) in dogs. 
 
An increase in IOP was seen at T10 after treatment and 
continued until maximum of IOP at T20 when increase 
was 2.6±2.8 mmHg higher than at pre-treatment 
(P=0.008). The IOP started to decrease at T25 and 
continued to decrease until 60 minutes after treatment. 
The IOP did not significantly change during the last 25 
minutes.  
At the last measurement the IOP was higher than in the 
contralateral eye, but this difference was not 
statistically significant. Mean IOP in the treated eye 
compared to the untreated eye and the control group 
values were higher throughout the measurement period 
but only significantly (P<0.05) from 10 until 25 
minutes after treatment (Fig. 3). In the contralateral eye, 
the IOP did not significantly increase throughout the 
treatment period, with IOP values varying from 
17.0±3.2 mmHg to 18.1±3.9 mmHg.  
Our results regarding the influence of topical 1% 
atropine on the horizontal pupil diameter show that 
there is no significant differences in the HPD between 
the eyes (P=0.17) before topical atropine (Table 2). 
The pupil was dilated at T10 after application of 1% 
atropine and continued to increase, gaining a maximum 
mean value of 12.1±1.7 mm at 60 minutes (P<0.003). 
HPD did not change in two last measurements (Fig. 4). 
The increase in pupil diameter from the pre-treatment 
value until the end of the study was 4.2±2.7 mm. 
Differences in the HPD between the treated and 
untreated eye were statistically significant (P<0.003) 
from 10 minutes after application of atropine until 60 
minutes or the end of study period.  
 
 
Fig. 4. Effect of 1% atropine sulphate on the horizontal pupil 
diameter (mean values) in dogs. 
 
Group 3 (phenylephrine) 
In the third group of dogs we investigated the effects of 
topical 10% phenylephrine on the IOP and the HPD. 
There were no significant differences in the IOP 
between the right eye and the left eye (Table 1) before 
topical application of phenylephrine (P>0.05).  
The effect of topical 10% phenylephrine is shown in 
Figure 5. 
 
 
Fig. 5. Effect of unilateral application of 10% phenylephrine 
on the intraocular pressure (mean values) in dogs. 
 
In the right eye IOP statistically significantly increased 
at T5 time point, compared to T0 values. The IOP 
continued to increase till T10 showing 17.3±4.1 
mmHg, having increase of 2.3±2.1 mmHg compare to 
T0 (P<0.05) and by T35 the IOP had decreased to 
14.9±2.3 mmHg. A second phase of IOP increase was 
recorded 45 minutes after treatment, with IOP rising to 
16.6±4.1 mmHg; however, the second increase of IOP 
was not statistically significant (P>0.05). At T55 IOP 
decreased to 14.8±1.4 mmHg, (Fig. 5), not statistically 
different from pre-treatment values (P>0.05). 
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Table 2. Effect of mydriatics on horizontal pupil diameter (mean values ± SD) in the dog’s right and left eye. 
 
Topical mydriatics 
Right eye (treated eye) Left eye (untreated eye) 
Initial HPD 
(mean ± SD) 
Maximal HPD 
(mean ± SD), time 
% of HPD  
increase 
Initial HPD 
(mean ± SD) 
Maximal HPD 
(mean ± SD), time 
% of HPD  
increase 
Tropicamide 6.6 ± 0.8 
13.2 ±1.7  
(55min) 
100% ** 6.8 ± 0.9 
7.1 ± 0.6  
(40min) 
4.4 
Atropine sulphate 7.9 ± 3.6 
12.1 ± 1.7 
(50 min) 
53.2 %** 7.7 ± 3.6 
7.9 ± 3.0 
(60 min) 
2.6 % 
Phenylephrine 
hydrochlorid 
7.9 ± 1.5 
9.9 ± 2.0 
(60 min) 
25.3% 7.7 ± 1.3 
6.5 ± 1.2 
(60 min) 
-15.6% 
Saline 7.1 ± 1.2 
7.3 ± 1.2 
(60 min) 
2.8% 7.1 ± 1.2 
7.3 ± 1.2 
(60 min) 
2.8% 
** P < 0.01 
 
Importantly, in the left, untreated eye we noticed 
changes in the IOP (Fig. 5.). As in right eye, the IOP 
increased in the first five minutes after treatment. 
Statistically significant IOP increases in the untreated 
eye were observed 10 and 20 minutes after application 
of phenylephrine; respectively 15.8±3.3 mmHg and 
16.3±2.3 mmHg (P<0.05), an increase of 1.8±2.1 
mmHg and 2.3±2.1 mmHg compared to pre-treatment 
values.  Between 35 and 60 minutes after treatment IOP 
returned to pre-treatment values (P>0.05). The mean 
IOP in the treated eye compared to the untreated eye 
was significantly higher (P<0.05) throughout the 
measurement period, except at 20 and 25 minutes after 
treatment (Fig. 5). The results regarding the effect of 
topical 10% phenylephrine on the HPD are shown in 
Table 2. The HPD was increased ten minutes after 
treatment in the right eye (Fig. 6.). Fifteen minutes after 
treatment it slightly decreased. Statistically significant 
increases of the HPD were obtained at T20 and T25 
minutes after phenylephrine (P<0.05). At T30 and T35 
minutes after treatment, the HPD decreased, but it was 
still significantly higher than the pre–treatment values 
(Fig. 6). The pupil diameter continued to enlarge 40 - 
60 minutes after treatment, being widest at the time of 
the last measurement (9.9±2.0 mm).  
 
 
Fig. 6. Effect of 10% phenylephrine on the horizontal pupil 
diameter (mean values) in dogs. 
 
In the left eye the HPD slightly decreased 15 minutes 
after treatment, and by 40 minutes had reached 6.5±1.2 
mm (Fig. 6), which was statistically significantly lower 
than before the topical administration of phenylephrine 
(P<0.05).  
Group 4 (saline) 
In the fourth group of dogs we investigated the effects 
of topical saline on the IOP and the HPD. There were 
no significant differences in the IOP between right and 
left eye (16.6±2.0 mmHg) before topical application of 
saline (P>0.05). The mean IOP of the treated eye 
compared to the untreated eye did not change 
significantly throughout the measurement period; the 
IOP values varied from 16.6±2.0 mmHg – 17.3±2.0 
mmHg. Our results regarding influence of topical saline 
on the HPD show that the mean HPD before application 
of saline in the right and the left eye was 7.1±1.2 mm; 
there were no significant differences in the HPD 
between eyes. Mean HPD in the treated eye compared 
to untreated eye did not significantly change throughout 
the measurement period (P>0.05). 
Discussion 
The IOP before drug administration in all dogs included 
in this study ranged from 12.8±1.8 mmHg to 17.7±3.1 
mmHg. This is similar to previously reported values – 
16.7±4.0 mmHg to 18.7±5.5 mmHg (Miller et al., 
1993; Gelatt and Mackay, 1998). In group 1 of this 
study we investigated the effects of topical 0.5% 
tropicamide on the IOP and the HPD during the first 
hour after treatment, to assess whether there is an 
increase in the IOP during diagnostic mydriasis. 
Contrary to the findings of Hacker and Farver (1988) 
where a significant increase in IOP was not observed 
after unilateral or bilateral tropicamide application, our 
research shows a significant increase in IOP 
immediately after unilateral application of 0.5% 
tropicamide while mydriasis was occurring. The IOP in 
the contralateral eye did not increase, showing no 
systemic influence. Importantly, the previous studies 
did not measure IOP throughout the period of mydriasis 
but merely at the point of maximal mydriasis (Hacker 
and Farver, 1988; Taylor et al., 2007) while we show 
an increase during the phase of increasing pupil size, 
returning to normal at the point of maximal dilation. In 
similar research in cats, after unilateral application of 
tropicamide, the IOP significantly increased in the 
treated eye 1 and 1.5 h after treatment (Stadtbaumer et 
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al., 2006). Our findings showed that during the period 
of mydriasis in dogs, a statistically significant increase 
was occurred. In group 2 we determined the effects of 
the longer-acting parasympatholytic cholinergic 
blocking agent 1% atropine sulphate. In the treated eye 
the IOP increased significantly 10 minutes after 
application of topical atropine, retaining the maximal 
effect for 20 minutes. During the same period the IOP 
in the untreated eye did not change, suggesting that 
there are no systemic effects of 1% atropine sulphate 
after topical application in one eye.  
Topical atropine increased the HPD, reaching a 
maximal pupil size maximum at 30 to 60 minutes after 
treatment, but without changing HPD in the 
contralateral eye.  This data is similar to that published 
by Gelatt, demonstrating maximal pupil dilation in 
dogs, cats and cows at 30-60 min after administration 
of atropine (Gelatt et al., 1973, 1995). 
Latest research shows that 0.5% tropicamide and 1% 
atropine counteracted 0.005% latanoprost miotic effect, 
with atropine caused significantly larger mydriasis, but 
in this combination neither drug counteracted the 
hypotensive effect of latanoprost during this study 
period in healthy Labrador retrievers (Kahane et al., 
2016). Novel results were obtained with unilateral 
application of 10% phenylephrine. As well as 
increasing IOP in the treated eye, the contralateral eye 
also showed a significant increase in IOP, 
demonstrating that phenylephrine is absorbed into the 
circulation from the eye and has a profound systemic 
influence. This correlates with research by Pascoe et al. 
(1994) and Herring et al. (2004), where topical 
application of phenylephrine increase blood pressure 
and heart rate, indicating systemic absorption.  
Studies regarding the influence of 10% phenylephrine 
on canine IOP have not been published in the literature 
until now, although studies in cats, monkeys and 
humans demonstrated no significant increase of IOP 
after topical application of phenylephrine in those 
species (Marchini et al., 2003; Takayama et al., 2004; 
Stadtbaumer et al., 2006). Ten percent phenylephrine 
showed opposite effects on the HPD in the treated as 
compared to the un-treated eye: in treated eye HPD 
increased, but in the contralateral eye HPD decreased.  
These results are perplexing and show the need for 
further research on this drug. 
In group 4, the control group, we investigated the 
effects of topical saline on the IOP and the HPD during 
the first hour after treatment. As we anticipated there 
were no changes in the IOP and the HPD in either eye 
during the full period of measurement. 
Conclusion 
In this study, contrary to previously published reports, 
we obtained an increase in the IOP in ophthalmically 
normal canine eyes undergoing mydriasis. The short 
period during which the IOP rises should not give rise 
for concern for normal dog eyes, but where glaucoma 
is possible, as in dogs predisposed by breed to 
glaucoma, where the iridocorneal angle is already 
abnormal as shown by gonioscopy or where the 
contralateral eye already has glaucoma, caution should 
be taken in the mydriasis of the remaining sighted eye. 
We do not know whether mydriasis of eyes at risk of 
glaucoma might lead to a catastrophic permanent 
increase in IOP. However, we feel that the novel results 
here should be taken into consideration when 
performing ophthalmic examinations of dogs with 
breed or family history of glaucoma, or ones where 
gonioscopy has shown dysplastic changes in the 
iridocorneal angle. Further research is needed to define 
more completely the mechanism or mechanisms that 
can cause an increase of the IOP. 
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